ArticleCancers2019

BCG Therapy of Bladder Cancer Stimulates a Prolonged Release of the Chemoattractant CXCL10 (IP10) in Patient Urine.

Omodele Ashiru et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.